Cargando…
Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis
BACKGROUND: Erectile dysfunction (ED), as one of the most prevalent consequences in male diabetic patients, has a serious impact on men's physical and mental health, and the treatment effect of diabetic mellitus erectile dysfunction (DMED) is often worse. Therefore, the development of a novel t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444126/ https://www.ncbi.nlm.nih.gov/pubmed/36064453 http://dx.doi.org/10.1186/s13287-022-03147-w |
_version_ | 1784783147432411136 |
---|---|
author | Feng, Huan Liu, Qi Deng, Zhiyao Li, Hao Zhang, Huajie Song, Jingyu Liu, Xiaming Liu, Jihong Wen, Bo Wang, Tao |
author_facet | Feng, Huan Liu, Qi Deng, Zhiyao Li, Hao Zhang, Huajie Song, Jingyu Liu, Xiaming Liu, Jihong Wen, Bo Wang, Tao |
author_sort | Feng, Huan |
collection | PubMed |
description | BACKGROUND: Erectile dysfunction (ED), as one of the most prevalent consequences in male diabetic patients, has a serious impact on men's physical and mental health, and the treatment effect of diabetic mellitus erectile dysfunction (DMED) is often worse. Therefore, the development of a novel therapeutic approach is urgent. As stem cells with high differentiation potential, human umbilical cord mesenchymal stem cells (HUCMSCs) have been widely used in the treatment of diseases in other systems, and are expected to be a promising strategy for the treatment of DMED. In this study, we investigated the role of HUCMSCs in managing erectile function in rat models of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) and compared the effects of two different injection methods. METHODS: T1DM and T2DM ED rats were given labelled HUCMSCs by corpus cavernosum injection and tail vein injection, respectively. ICP and MAP were monitored simultaneously by electrical stimulation four weeks after injection to indicate the erectile function of rats. To track the development and colonisation capabilities of stem cells, we performed EdU assay with penile tissue. The histological changes of the penis were observed by hematoxylin–eosin staining, and Masson’s trichrome staining was conducted to evaluate the smooth muscle content and the degree of fibrosis in the rat penis. Then, we employed specific kits to measure the level of NO, cGMP, MDA, SOD and Fe in penis. Electron transmission microscopy was implemented to observe morphology of mitochondria. Besides, western blot and immunofluorescence staining were performed to demonstrate the expression of ferroptosis-related genes. RESULTS: We found that HUCMSCs improved erectile function in T1DM and T2DM ED rats, with no difference in efficacy between corpus cavernosum injection and tail vein injection. The EdU assay revealed that only a tiny percentage of HUCMSCs colonised the corpus cavernosum, while smooth muscle in the penis expanded and collagen decreased following HUCMSC injection. Moreover, the levels of oxidative stress in the penis of the rats given HUCMSCs were dramatically reduced, as was the tissue iron content. HUCMSCs normalised mitochondrial morphology within corpus cavernosum smooth muscle cells (CCSMCs), which were characteristically altered by high glucose. Furthermore, the expression of ferroptosis inhibitory genes SLC7A11 and GPX4 was obviously elevated in CCSMCs after stem cell management, but the abundances of ACSL4, LPCAT3 and ALOX15 showed the polar opposite tendency. CONCLUSIONS: HUCMSCs can effectively and safely alleviate erectile dysfunction in T1DM and T2DM ED rats, while restoring erectile function by attenuating diabetes-induced ferroptosis in CCSMCs. Additionally, this study provides significant evidence for the development of HUCMSCs as a viable therapeutic strategy for DMED. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03147-w. |
format | Online Article Text |
id | pubmed-9444126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94441262022-09-06 Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis Feng, Huan Liu, Qi Deng, Zhiyao Li, Hao Zhang, Huajie Song, Jingyu Liu, Xiaming Liu, Jihong Wen, Bo Wang, Tao Stem Cell Res Ther Research BACKGROUND: Erectile dysfunction (ED), as one of the most prevalent consequences in male diabetic patients, has a serious impact on men's physical and mental health, and the treatment effect of diabetic mellitus erectile dysfunction (DMED) is often worse. Therefore, the development of a novel therapeutic approach is urgent. As stem cells with high differentiation potential, human umbilical cord mesenchymal stem cells (HUCMSCs) have been widely used in the treatment of diseases in other systems, and are expected to be a promising strategy for the treatment of DMED. In this study, we investigated the role of HUCMSCs in managing erectile function in rat models of type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) and compared the effects of two different injection methods. METHODS: T1DM and T2DM ED rats were given labelled HUCMSCs by corpus cavernosum injection and tail vein injection, respectively. ICP and MAP were monitored simultaneously by electrical stimulation four weeks after injection to indicate the erectile function of rats. To track the development and colonisation capabilities of stem cells, we performed EdU assay with penile tissue. The histological changes of the penis were observed by hematoxylin–eosin staining, and Masson’s trichrome staining was conducted to evaluate the smooth muscle content and the degree of fibrosis in the rat penis. Then, we employed specific kits to measure the level of NO, cGMP, MDA, SOD and Fe in penis. Electron transmission microscopy was implemented to observe morphology of mitochondria. Besides, western blot and immunofluorescence staining were performed to demonstrate the expression of ferroptosis-related genes. RESULTS: We found that HUCMSCs improved erectile function in T1DM and T2DM ED rats, with no difference in efficacy between corpus cavernosum injection and tail vein injection. The EdU assay revealed that only a tiny percentage of HUCMSCs colonised the corpus cavernosum, while smooth muscle in the penis expanded and collagen decreased following HUCMSC injection. Moreover, the levels of oxidative stress in the penis of the rats given HUCMSCs were dramatically reduced, as was the tissue iron content. HUCMSCs normalised mitochondrial morphology within corpus cavernosum smooth muscle cells (CCSMCs), which were characteristically altered by high glucose. Furthermore, the expression of ferroptosis inhibitory genes SLC7A11 and GPX4 was obviously elevated in CCSMCs after stem cell management, but the abundances of ACSL4, LPCAT3 and ALOX15 showed the polar opposite tendency. CONCLUSIONS: HUCMSCs can effectively and safely alleviate erectile dysfunction in T1DM and T2DM ED rats, while restoring erectile function by attenuating diabetes-induced ferroptosis in CCSMCs. Additionally, this study provides significant evidence for the development of HUCMSCs as a viable therapeutic strategy for DMED. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03147-w. BioMed Central 2022-09-05 /pmc/articles/PMC9444126/ /pubmed/36064453 http://dx.doi.org/10.1186/s13287-022-03147-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Feng, Huan Liu, Qi Deng, Zhiyao Li, Hao Zhang, Huajie Song, Jingyu Liu, Xiaming Liu, Jihong Wen, Bo Wang, Tao Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
title | Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
title_full | Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
title_fullStr | Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
title_full_unstemmed | Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
title_short | Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
title_sort | human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444126/ https://www.ncbi.nlm.nih.gov/pubmed/36064453 http://dx.doi.org/10.1186/s13287-022-03147-w |
work_keys_str_mv | AT fenghuan humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT liuqi humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT dengzhiyao humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT lihao humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT zhanghuajie humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT songjingyu humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT liuxiaming humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT liujihong humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT wenbo humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis AT wangtao humanumbilicalcordmesenchymalstemcellsameliorateerectiledysfunctioninratswithdiabetesmellitusthroughtheattenuationofferroptosis |